'Biologic therapy' presentation slideshows

Contemporary Issues in Psoriasis Care: A Call to Action

Contemporary Issues in Psoriasis Care: A Call to Action. Psoriasis. Types of Psoriasis. Psoriasis Statistics: United States. Genetics and Environmental Triggers. Immunologic Basis of Psoriasis. Psoriatic Arthritis. Role of the Dermatologist in Identifying Psoriatic Arthritis .

595 views • 37 slides

New agents and strategies in AML and high-risk MDS

New agents and strategies in AML and high-risk MDS. ???? ????? ? ? ?. Advances in understanding the cell biology, molecular abnormalities Development of novel targeted therapy Understanding mechanisms of drug resistance, synergistic actions Reinforcement of existing therapy

530 views • 30 slides

BAD Biologic Interventions Register (BADBIR )

BAD Biologic Interventions Register (BADBIR ). An update November 2010. Presentation Overview. Project rationale Brief history of BADBIR Aim and study design Data collection Conclusions. The advent of biologic agents. Has been met with:

380 views • 21 slides

Terminology in Health Care and Public Health Settings

Terminology in Health Care and Public Health Settings. Unit 12 Urinary System. Urinary System. Objectives Define, understand and correctly pronounce medical terms related to the urinary system

236 views • 11 slides

Terminology in Health Care and Public Health Settings

Terminology in Health Care and Public Health Settings. Unit 12 Urinary System. Urinary System. Objectives Define, understand and correctly pronounce medical terms related to the urinary system

170 views • 11 slides

Breast Cancer By: Najiyah Westry , Mikaela Dailey, and Melody Scott

Breast Cancer By: Najiyah Westry , Mikaela Dailey, and Melody Scott. Description.

216 views • 7 slides

Immunotherapy and its Side Effects

Immunotherapy is a biologic therapy which is a type of cancer treatment that boosts the body's natural defenses for fighting against cancer. It uses substances made by the human body or in a laboratory for improving or restoring the immune systemu2019s function. https://www.voiceofcancerpatients.com/all-cancers/cancer-therapy/immunotherapy

52 views • 4 slides

Table 1 Persistent benefits after withdrawal of biologic therapy for pJIA in RCWTs

Table 1 Persistent benefits after withdrawal of biologic therapy for pJIA in RCWTs. Southwood, T. R. (2014) Treatment of JIA in the biologic era: what are we waiting for? Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.14.

167 views • 1 slides

Figure 2 Potential intracellular targets for biologic therapy of RA

258 views • 1 slides

nrrheum.2013.197-pf2

Figure 2 Suggested algorithm for assessment, monitoring and management of patients with RA?ILD on biologic therapy. Jani, M. et al. (2013) The safety of biologic therapies in RA?associated interstitial lung disease Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2013.197.

144 views • 1 slides

Table 1 Possible molecular targets and corresponding biologic agents in SLE

Table 1 Possible molecular targets and corresponding biologic agents in SLE. Stohl, W. (2013) Future prospects in biologic therapy for systemic lupus erythematosus Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2013.136.

132 views • 1 slides

Figure 4 The BAFF axis and its inhibition

Figure 4 The BAFF axis and its inhibition. Stohl, W. (2013) Future prospects in biologic therapy for systemic lupus erythematosus Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2013.136.

196 views • 1 slides